epcoritamab
abbvie,genmab
['lymphoma', 'epcoritamab', '$gmab', '$abbv']
$gmab $abbv genmab announces late-breaking phase 2 trial results of investigational epcoritamab (duobody -cd3xcd20) in relapsed/refractory large b-cell lymphoma (lbcl) patients presented at european hematology association (eha) presidential symposium 
News and analysis of biomedical, biopharma, biotech, biosciences, pharmaceutical, and technology equities